| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0064 | 1 |